Related Experiment Video

Updated: Aug 18, 2026

The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms
05:57

The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms

Published on: July 2, 2013

[Treatment of chronic osteomyelitis with gentamicin PMMA chains]

K Klemm, M Börner

    Unfallchirurgie
    |June 1, 1986
    PubMed

    Insights

    Radical removal of infected bone is key for chronic osteomyelitis treatment. Gentamicin-PMMA chains offer high local antibiotic levels, minimizing systemic toxicity risks.

    Area of Science:

    • Orthopedic Surgery
    • Infectious Diseases
    • Biomaterials Science

    Context:

    • Chronic osteomyelitis requires aggressive treatment, often involving surgical debridement.
    • Antibiotic therapy alone is insufficient for eradicating established bone infections.
    • Sequestrated bone fragments impede healing and harbor persistent pathogens.

    Purpose:

    • To evaluate the efficacy of gentamicin-polymethylmethacrylate (PMMA) chains in treating chronic osteomyelitis.
    • To assess the local antibiotic delivery and systemic safety profile of gentamicin-PMMA chains.
    • To determine the optimal indications for gentamicin-PMMA chain implantation.

    Summary:

    • Radical removal of sequestrated bone is crucial in chronic osteomyelitis management.
    • Gentamicin-PMMA chains deliver high local concentrations of gentamicin, exceeding minimal bactericidal concentrations for common pathogens.
    • This localized delivery minimizes systemic antibiotic levels, mitigating risks of nephrotoxicity and ototoxicity.

    Impact:

    • Gentamicin-PMMA chains provide an effective adjunctive treatment for chronic osteomyelitis.
    • The method is particularly indicated for chronic sequestrating osteosynthesis and infected non-unions.
    • This approach enhances infection control while preserving patient safety by avoiding systemic side effects.

    More Related Videos

    Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection09:09

    Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection

    Published on: March 14, 2019

    Amikacin Protection Assay for Quantification and Visualization of Escherichia coli Cell Invasion09:22

    Amikacin Protection Assay for Quantification and Visualization of Escherichia coli Cell Invasion

    Published on: July 3, 2026

    Related Concept Videos

    Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

    Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

    Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
    Mechanism of Antibiotic Resistance in MRSA01:25

    Mechanism of Antibiotic Resistance in MRSA

    Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
    Clinical Significance of Antibiotic Resistance01:25

    Clinical Significance of Antibiotic Resistance

    Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...